Cresanto Global P/B Ratio

Current P/B Ratio
-0.7
Low Valuation
Very Low - Significant discount to book value, potential distress or value opportunity

Cresanto Global (CRESANTO) P/B ratio is -0.7 (Low), book value per share ₹-7.50 vs Healthcare average P/B of -0.31 — Very Low - Significant discount to book value, potential distress or value opportunity. View Cresanto Global 52-week for the annual high/low range and current price position.

Current Valuation Metrics

P/B Ratio -0.7
Current Price ₹4.65
Book Value/Share ₹-7.50
Exchange BSE

Book Value Breakdown (2025)

Balance Sheet Components
Total Equity ₹-3 Cr
Share Capital ₹4 Cr
Reserves & Surplus ₹-7 Cr
Outstanding Shares 4,000,000
Book Value per Share ₹-7.50

Valuation Signal

Signal Undervalued

Sector Context

Sector Average -0.31
Sector Median 0.65
Sector Rank #9 of 50
Sector Percentile 18.0%

CRESANTO P/B Ratio — Valuation Insights & Book Value Analysis

Cresanto Global price-to-book ratio interpretation, valuation status and historical context — current P/B -0.7 (Low). For live price, earnings yield and the full fundamental profile, see Cresanto Global screener.

  • Stock appears undervalued with PB of -0.7, trading below book value
  • Trading below book value - potential value opportunity or financial distress signal
  • Trading at discount to sector average PB of -0.31

CRESANTO vs Healthcare Peers — P/B Ratio Comparison

Cresanto Global P/B -0.7 vs Healthcare average -0.31, median 0.65 — range -18.41–1.12.

Sector Average
-0.31
Sector Median
0.65
Lowest P/B
-18.41
Highest P/B
1.12
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Rekvina Laboratories VINRKLB -18.41 ₹23 Low
Span Divergent SDL -6.32 ₹19 Low
Oxygenta Pharmaceutical OXYGENTAPH -5.54 ₹203 Low
Satiate Agri SATAGRI -3.39 ₹8 Low
Parmax Pharma PARMAX -3.24 ₹23 Low
Adline Chem Lab ADLINE -3.03 ₹5 Low
Bharat Immunologicals BIBCL -2.31 ₹75 Low
Krebs Biochemicals & Ind… KREBSBIO -0.86 ₹142 Low
Vivimed Labs VIVIMEDLAB -0.57 ₹49 Low
Triochem Products TRIPR 0.04 ₹0 Low